Targeting the Gut Microbiota in Chagas Disease: What Do We Know so Far?

Duarte-Silva, Eduardo; Morais, Livia H; Clarke, Gerard; Savino, Wilson; Peixoto, Christina

Duarte-Silva, Eduardo; Morais, Livia H; Clarke, Gerard; Savino, Wilson; Peixoto, Christina.

Afiliação

Duarte-Silva E; Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ-PE), Recife, Brazil.
Morais LH; Postgraduate Program in Biosciences and Biotechnology for Health (PPGBBS), Aggeu Magalhães Institute (IAM), Recife, Brazil.
Clarke G; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Recife, Brazil.
Savino W; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, United States.
Peixoto C; Department of Psychiatry and Neurobehavioural Science, University College Cork, Cork, Ireland.

Front Microbiol ; 11: 585857, 2020.

Article em En | MEDLINE | ID: mdl-33362735

Palavras-chave

Chagas disease; Trypanosoma cruzi; gut microbiota; prebiotics; probiotics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Microbiol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil